FIGURE 3.
Trends in attribution of HPV16 and HPV18 to invasive cervical cancer by age group: The MINT study, 2011–2022. Year‐on‐year trends of HPV16/18 prevalence (broken lines) and estimated prevalence trends (straight lines) among women diagnosed with invasive cervical cancer are shown for two age groups (20–29 years [red] and 30–39 years [green]). Asterisks indicate a marginally significant decline (p = 0.05).